tiprankstipranks
Trending News
More News >
Elixirr International Plc (GB:ELIX)
LSE:ELIX

Elixirr International Plc (ELIX) AI Stock Analysis

Compare
26 Followers

Top Page

GB:ELIX

Elixirr International Plc

(LSE:ELIX)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
959.00p
▲(14.17% Upside)
Elixirr International Plc's overall stock score is driven by its strong financial performance and positive corporate events, which highlight its growth trajectory and strategic positioning. However, bearish technical indicators suggest caution in the short term. The valuation is fair, supporting a balanced investment outlook.
Positive Factors
Sustained Revenue Growth
Consistent double-digit revenue growth expands scale economics and demonstrates rising market demand for Elixirr's consulting services. Over a 2-6 month horizon this supports reinvestment in talent and offerings, strengthens client momentum, and underpins long-term competitive positioning.
Strong Balance Sheet
Low leverage and a high equity ratio provide durable financial flexibility to fund hiring, pursue M&A, or absorb downturns without heavy refinancing. This conservative capital structure reduces liquidity risk and supports strategic optionality over multiple quarters.
Robust Cash Generation
Strong operating cash conversion and rising free cash flow create internal funding for growth initiatives, dividends, or tuck-in acquisitions. Reliable cash generation reduces dependence on external financing and supports sustainable investment in capabilities and margins.
Negative Factors
Negative EPS Trend
A negative EPS growth metric signals that earnings per share declined, potentially from margin pressure, dilution or one-offs. If persistent, weaker EPS undermines capital return capacity and signals operational or profitability issues that could constrain medium-term shareholder value.
Project-Based Revenue Variability
Reliance on project-based consulting creates lumpy, timing-sensitive revenue and limited forward visibility. Client budget cycles and variable contract lengths increase cyclicality and complicate capacity planning, which can pressure utilization and margin stability across quarters.
Limited Public Guidance / Calls
Absence of earnings call detail and formal guidance reduces transparency for investors and analysts, making forecasting harder and potentially increasing perceived execution risk. Limited forward disclosure can persist for months and hinder market confidence in progress tracking.

Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)

Elixirr International Plc Business Overview & Revenue Model

Company DescriptionElixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers its services for various industries, such as automotive and transportation, manufacturing, business and financial services, charities, energy, utilities and resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and leisure, telecommunications, technology, retail and consumer goods, private equity, media, and entertainment and sports industries. Elixirr International plc was founded in 2009 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyElixirr generates revenue primarily through its consulting services, charging clients for project-based work and ongoing advisory services. The company's revenue model is based on fees for consultancy projects, which can vary in complexity and duration. Key revenue streams include management consulting, digital strategy, and operational efficiency projects. Elixirr also benefits from long-term partnerships with various organizations, which can lead to recurring revenue through extended contracts and follow-on work. Additionally, the firm may engage in performance-based contracts where fees are tied to the successful implementation of strategies that drive client growth and efficiency.

Elixirr International Plc Financial Statement Overview

Summary
Elixirr International Plc demonstrates robust financial performance with strong revenue growth, efficient operations, and solid profitability. The company maintains a healthy balance sheet with low leverage and high equity, alongside impressive cash flow management.
Income Statement
89
Very Positive
Elixirr International Plc has demonstrated robust growth in revenue with a year-over-year increase from 2023 to 2024. The company maintains strong profitability, evidenced by a healthy gross profit margin and net profit margin. The EBIT and EBITDA margins indicate efficient operational management. Overall, the income statement reflects a solid and growing company with strong financial performance.
Balance Sheet
85
Very Positive
The company's balance sheet is strong, with a low debt-to-equity ratio, reflecting prudent financial management. The equity ratio is high, indicating a stable capital structure with significant stockholders' equity relative to total assets. Return on equity remains attractive, showcasing the company's ability to generate returns for shareholders. The company's financial stability is underscored by its solid asset base and manageable liabilities.
Cash Flow
87
Very Positive
Elixirr International Plc exhibits impressive cash flow management, highlighted by substantial free cash flow growth. The operating cash flow to net income ratio is strong, indicating efficient conversion of income into cash. Free cash flow to net income is well-aligned, signaling effective reinvestment and financial strategy. The cash flow statements reflect a healthy liquidity position and sound financial practices.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue129.72M111.34M85.89M71.75M50.61M30.32M
Gross Profit41.91M35.81M29.26M23.16M17.70M11.19M
EBITDA31.87M27.96M25.78M20.02M14.46M8.97M
Net Income18.56M16.38M17.24M12.87M10.14M4.79M
Balance Sheet
Total Assets170.17M175.89M154.40M128.66M107.17M87.00M
Cash, Cash Equivalents and Short-Term Investments2.84M7.53M18.13M20.43M31.80M17.50M
Total Debt14.15M4.90M5.36M5.14M5.25M5.29M
Total Liabilities50.06M43.78M34.84M32.74M21.13M16.31M
Stockholders Equity120.12M132.11M119.56M95.92M86.04M70.69M
Cash Flow
Free Cash Flow29.78M28.76M16.67M15.40M14.23M12.12M
Operating Cash Flow29.86M28.84M16.79M15.73M14.33M12.15M
Investing Cash Flow-26.08M-21.11M-14.82M-18.53M-3.24M-1.46M
Financing Cash Flow-23.26M-18.58M-4.06M-8.85M3.11M3.88M

Elixirr International Plc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price840.00
Price Trends
50DMA
812.08
Positive
100DMA
819.83
Positive
200DMA
764.18
Positive
Market Momentum
MACD
12.98
Negative
RSI
57.15
Neutral
STOCH
60.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Positive. The current price of 840 is above the 20-day moving average (MA) of 839.10, above the 50-day MA of 812.08, and above the 200-day MA of 764.18, indicating a bullish trend. The MACD of 12.98 indicates Negative momentum. The RSI at 57.15 is Neutral, neither overbought nor oversold. The STOCH value of 60.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
£412.39M21.8615.29%2.13%32.67%-1.61%
71
Outperform
£512.80M15.6827.48%3.65%5.78%-6.80%
70
Outperform
£264.19M22.9210.14%3.78%3.22%-71.97%
69
Neutral
£872.52M59.603.76%1.19%9.25%-51.82%
66
Neutral
£212.55M34.296.18%1.83%23.37%4.75%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
53
Neutral
£84.85M-5.73-11.22%12.88%-14.31%-361.93%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ELIX
Elixirr International Plc
852.00
134.37
18.72%
GB:GFRD
Galliford Try
532.00
154.36
40.87%
GB:DATA
GlobalData
120.00
-64.38
-34.92%
GB:RWA
Robert Walters
129.00
-163.50
-55.90%
GB:WIL
Wilmington
295.00
-50.63
-14.65%
GB:FNTL
Fintel PLC
212.00
-50.19
-19.14%

Elixirr International Plc Corporate Events

Other
Elixirr Discloses Share Sale by Co-Founder’s Family Member, Ferguson Retains 4.5% Stake
Neutral
Jan 9, 2026

Elixirr International plc has disclosed that Amanda Ferguson, the wife of co-founder and board adviser Ian Ferguson, sold 2,998 ordinary shares in the company on 8 January 2026 at 834p per share. Following the transaction, Ian Ferguson remains beneficially interested in 2,237,385 shares, representing about 4.51% of Elixirr’s issued share capital, indicating that despite the family’s partial disposal, his stake and alignment with shareholders remain significant.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £866.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025